Sequent Scientific Share Price Target 2025
Sequent Scientific is a company leading in the sector of animal healthcare products. It has expanded its business internationally in many western countries. The main product of this company is the APIs (Active Pharmaceutical Ingredients). Sequent ‘s Current Market price stands at Rs.175 on NSE as of Date 24th December 2024.
Some Highlights of the Sequent Scientific are as follows:
- This Company has an established presence in over 100 countries in the entire world.
- Products are high demanding and Futuristic.
- Robust R&D initiatives with several pipeline products.
Sequent Scientific Share- Market Overview and Details
- Market Cap-₹ 4,414 Cr.
- Current Price-₹ 175
- High / Low-₹ 241 / 91.8
- Stock P/E-207
- Book Value-₹ 27.2
- Dividend Yield-0.00 %
- ROCE-0.44 %
- ROE-3.09 %
- Face Value-₹ 2.00
If You Want more Detailed overview of the company you can visit the site mentioned below-
Sequent Scientific Limited Share Price Today, Stock Price, Live NSE News, Quotes, Tips – NSE India
Sequent Scientific Share Price Chart –
Sequent Scientific Ltd , NSE
https://www.tradingview.com/chart/mJxJDFC1/?symbol=NSE%3ASEQUENT
Sequent Scientific Share Price Target For Upcoming Years 2025-2030
| Year | Sequent Scientific Share Price Target |
| 2025 | 245 |
| 2026 | 365 |
| 2027 | 510 |
| 2028 | 670 |
| 2029 | 830 |
| 2029 | 985 |
The Main Factors that can lead to Sequent Scientific’s Growth Story and its Share Price are-
- The Animal healthcare sector is expected to grow at high pace due to increased awareness of people. And Sequent Scientific will get benefitted from this industry’s growth.
- Sequent Scientific also gets benefit from other country’s governments and get regulatory approvals due to transparency and honesty.
- As the Pharma Export Sector is expected to boom in upcoming years,Market players like Sequent Scientific will get more oppurtunity to grow.
Some of the Strategic Initiatives taken by Sequent Scientific –
Sequent Scientific has undertaken several strategic initiatives for its growth in upcoming years-
- Expansion of manufacturing capacity in India.
- Investment in R&D to develop niche products.
- Collaboration with multinational companies to strengthen its global presence
However there are also some unavoidable Risks and challenges associated with Sequent Scientific’s growth,Listed below are few of them –
- Regulatory Risks: Non-compliance with important regulations could impact market access.
- Currency Fluctuations: As a global player, Sequent Scientific’s revenues are susceptible to forex risks.
- Competition: The pharmaceutical sector is highly competitive, requiring constant innovation and strategic moves to beat the competitors.
These are some risks associated with Sequent Scientific’s Growth.
Sequent Scientific Ltd Financials –
| Market Capitalization | 4414 Cr |
| Price to Book | 6.1 |
| Net Profit TTM | 17.1 |
| Basic EPS TTM | 0.7 |
| ROE Annual % | -5.5% |
| PEG TTM | 1.9 |
| PE TTM | 216.7 |
| Revenue Growth Qtr YoY% | 6.6 |
Sequent Scientific Shareholding Pattern-
| Entity | Holding % |
| Promoter | 52.76% |
| Public | 30.63% |
| FII | 6.45% |
| MF | 7.41% |
| Others | 2.8% |
Disclaimer:- We strongly recommend that you do not base your investment decisions solely on this website. These target prices are speculative forecasts, and investing in the stock market carries inherent risks. The information provided here is intended for informational and educational purposes only and should not be construed as financial advice or specific stock recommendations. Please Consult your Financial Advisor before investing.